Source: Wikipedia, the free encyclopedia.
Chemical compound
EGLU ((2S)-α-ethylglutamic acid ) is a drug that is used in neuroscience research. It was one of the first compounds found that acts as a selective antagonist for the group II metabotropic glutamate receptors (mGluR2/3), and so has been useful in the characterization and study of this receptor subfamily.[1][2][3][4][5][6][7]
References
|
---|
Group I | mGluR1Tooltip Metabotropic glutamate receptor 1 | |
---|
mGluR5Tooltip Metabotropic glutamate receptor 5 | |
---|
|
---|
Group II | mGluR2Tooltip Metabotropic glutamate receptor 2 | |
---|
mGluR3Tooltip Metabotropic glutamate receptor 3 | |
---|
|
---|
Group III | mGluR4Tooltip Metabotropic glutamate receptor 4 | |
---|
mGluR6Tooltip Metabotropic glutamate receptor 6 |
- Agonists:
Glutamate
- L-AP4
|
---|
mGluR7Tooltip Metabotropic glutamate receptor 7 | |
---|
mGluR8Tooltip Metabotropic glutamate receptor 8 | |
---|
|
---|
|